International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationRTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer
Introduction
Pelvic lymph node (LN) radiation was a required part of the treatment for high-risk/locally advanced prostate cancer patients treated on all the prospective randomized trials used to establish the role of hormone therapy and radiation for this patient population 1, 2, 3, 4. In addition, published data suggest that treating these volumes may improve outcomes for prostate cancer patients if the risk of lymph node involvement is significant (5). Furthermore, there are two open Radiation Therapy Oncology Group (RTOG) trials for high-risk prostate cancer patients who require pelvic lymph node radiation therapy 6, 7.
The challenge is that there are significant differences of opinion regarding appropriate pelvic LN volumes to be treated in this cohort of patients. A 2007 survey of RTOG genitourinary (GU) cancer experts indicated that significant variability existed among a group of radiation oncologists experienced in the treatment of prostate cancer and design of prostate cancer clinical trials (8). Given the widely adopted use of intensity-modulated radiation therapy to treat the pelvic lymph nodes and spare organs at risk (OAR) it is imperative that a consensus be obtained to establish the appropriate nodal volumes for these patients so that the relative safety and merit of such treatment can be established. The purpose of this study was to establish such a consensus.
Section snippets
Materials and Methods
Given the established variability in LN treatment volumes by the RTOG GU Radiation Oncologists, a consensus meeting was held on October 3, 2007, sponsored by the RTOG. All physicians/institutions involved in the original contouring project were invited to attend (8). Data were presented (C.L.) to address the lymph node drainage of the prostate using prostatic lymphography, extended lymph node dissection, the sentinel lymph node concept, anatomy texts, pelvic magnetic resonance imaging imaging,
Results
Data presented regarding prostatic lymphography 9, 10 reveal prostatic lymph node drainage to the internal iliac, external iliac, presacral and common iliac nodes, with the main drainage to the internal iliac and presacral lymph nodes (9).
Extended lymph node dissection data, which generally involved resection of the external and internal iliac and obturator lymph nodes as well as the common and presacral lymph nodes, showed evidence of nodal drainage in multiple nodal sites 11, 12, 13, 14, 15.
Conclusions
Adenocarcinoma of the prostate is the second most common cause of cancer death in US males with more than 27,000 deaths estimated for 2007 (23). Many of these patients will have presented with locally advanced/high-risk disease where regional pelvic lymph node involvement is a reality. The role of radiation therapy in the cure of these patients is evolving, but certainly many can be controlled if not cured with the use of radiation and hormonal manipulation 3, 4, 12. These cures are the result
References (24)
- et al.
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma long term results of phase III RTOG 85-31
Int J Radiat Oncol Biol Phys
(2005) - et al.
Long term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study, a phase III randomized trial)
Lancet
(2002) - et al.
Whole-pelvis, “mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial
Int J Radiat Oncol Biol Phys
(2006) - et al.
Variation in the definition of clinical target volumes for pelvic node conformal radiation therapy of prostate cancer
Int J Radiat Oncol Biol Phys
(2007) - et al.
An evaluation of lymphangiography in staging carcinoma of the prostate
J Urol
(1975) - et al.
Extended pelvic lymphadenectomy for prostate cancer
J Urol
(1979) - et al.
Is a limited node dissection an adequate staging procedure for prostate cancer?
J Urol
(2002) - et al.
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis
J Urol
(2002) - et al.
Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer
J Urol
(2004) - et al.
Validity of sentinel lymph node concept for patients with prostate cancer
J Urol
(2004)
Sentinel lymph node dissection for prostate cancer: Experience with more than 1,000 patients
J Urol
Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy
J Int Radiat Oncol Biol Phys
Cited by (337)
Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis
2024, International Journal of Radiation Oncology Biology PhysicsDose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial
2024, International Journal of Radiation Oncology Biology PhysicsIs Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial
2024, International Journal of Radiation Oncology Biology PhysicsConsensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU)
2024, International Journal of Radiation Oncology Biology PhysicsThe main approaches in the management of localized prostate cancer
2023, Medecine NucleaireElective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 3 Trial
2023, Advances in Radiation Oncology
Supported by grants from the National Cancer Institute, CA21661, CA32115, and CA37422.
Conflict of interest: none